4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001144204-15-021797
CIK 0001335103operating
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:10 PM ET
Size
6.0 KB
Accession
0001144204-15-021797
Insider Transaction Report
Form 4
ANTOLINE STEVE
Director10% Owner
Transactions
- Other
Warrant (right to buy)
2015-04-06+1,630,000→ 1,630,000 total(indirect: See Footnote)Exercise: $0.45From: 2015-04-06Exp: 2020-04-06→ Common Stock (1,630,000 underlying)
Footnotes (2)
- [F1]On April 1, 2015, the Issuer's Board of Directors authorized the issuance to Summit Resources, Inc. ("Summit") of a five-year warrant to purchase 1,630,000 shares of Common Stock, at an exercise price of $0.45 per share, in consideration of financial and other support previously provided by Summit to the Issuer.
- [F2]The Warrant is owned of record by Summit. The Reporting Person has voting and dispositive control over securities owned of record by Summit and may be deemed to beneficially own the Warrant held of record by Summit.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:10 PM ET
- Size
- 6.0 KB